Transphorm, Inc (TGAN) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts TGAN Hot Sheet
Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Transphorm, Inc (NASDAQ: TGAN) reported Q4 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $4.93 million versus the consensus estimate of $4.92 million.
For earnings history and earnings-related data on Transphorm, Inc (TGAN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LiveOne (LVO) Tops Q4 EPS by 2c
- UPDATE: JMP Securities Upgrades Seven Hills Realty Trust (SEVN) to Market Outperform
- Evolent Health (EVH) Acquires IPG for $375M + Up to $87M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
